Qualified Person Education Course Module B

5/6 June 2025, Vienna, Austria

Course No. 21575

header-image

Speakers

Georg Göstl

Georg Göstl

Takeda Manufacturing Austria

Dr Ulrich Kissel

Dr Ulrich Kissel

European QP Association (EQPA), KisselPharmaConsulting

Dr. Jens-Uwe Rengers

Dr. Jens-Uwe Rengers

vorm. Akorn

Ewa Rybak

Ewa Rybak

Polpharma Biologics

Dr. Sue Mann

Dr. Sue Mann

Sue Mann Consultancy

Objectives

Broaden your knowledge of the Qualified Person’s duties and see and discuss which responsibilities and tasks are parts of a QP’s daily life – besides batch certification. With fulfilling these tasks, the QP has a lot of interfaces and interactions. How this can be managed will be a topic in Module B and its pre-course session on soft skills.

Background

Over the last years the role and responsibilities of the Qualified Person have been increasing considerably. As a key person in the company, the QP has to consider many issues and has to take up the challenges within its areas of responsibilities. Additionally, as laid out in Article 49 of the European Directive 2001/83/EC, the QP needs to be highly qualified and experienced. EQPA’s education course modules will help the QP to be well prepared and to be on top of current developments in GMP and regulatory requirements.

Target Group

New and practicing Qualified Persons who are looking for ongoing training and want to improve their effectiveness and liaison with other functions.

Programme

Qualified Person Education Course Module B

Seminar Programme as PDF

QP Interfaces
  • Which roles are essential for a QP to work efficiently and effectively (e.g. Head of Production, Head of Quality Control, QPPV, QA)
  • Identifying the best working practice for QPs working with colleagues in supportive roles
  • Links with regulatory authorities and inspectors
Import – Export – Product Flow
  • Applicable legislation: a view on Annex 16 and Annex 21
  • Different Mutual Recognition Agreements (MRAs)
  • What’s expected with regard to Supplier Qualification, Supply Chain Overview, Re-Testing and PQ
Interpretation of Data (with a Focus on Batch Documentation and the PQR)
  • Which key figures are relevant for the QP?
  • Data verification: determining the acceptability of data
  • When is a system or process deemed to be robust?
  • Necessary key figures: always easy to understand?
  • When is a trend a trend? And what to do with OOT (out of trend)?
Workshop: Interpretation of Data
  • Learn how to interpret data and understand the consequences of appropriate and inappropriate performance Parameters
  • Evaluate with other delegates the content and lay-out of given examples and discuss it with the speakers
Human Error
  • What is behind “Human Error”?
  • What the QP needs to know about it
  • Is Human error avoidable?
  • Human error and Data Integrity issues
How to ensure that a Batch is in Compliance with the Requirements of its Marketing Authorisation (MA)
  • Structure of the MA – which are the relevant parts for the QP?
  • How to keep the QP Declaration up to date?
  • How can the QP ensure compliance?
  • Involvement in Change Control processes
  • Challenges for the QP
  • Possible Work Flows
Quality Risk Management for the QP
The term “quality risk management” is used throughout Annex 16. But how could the QP use this tool? In this session you will get some practical advice!
 
QP Involvement in Investigations and CAPA
  • QP role in deviation process
  • QP role in handling of product deviations
  • Does QP need to be involved in all deviations?
  • QP final decision regarding product deviation and Batch certification
  • QP involvement in product complaints
  • Tools for performing investigations
  • The importance of CAPA in the deviation process
  • Workshop with examples

Case studies: What the QP should know about
  • Pharmaceutical Quality System
  • Batch Record Review
  • Management Review
    (With possibility for interaction)

ECA-Member*: € 1690,-
Non ECA Member*: € 1890,-
EU/GMP Inspectorates*: € 945,-
QP Member Discount*: € 1690,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023